Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Minority Interest (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Minority Interest for 17 consecutive years, with $33.0 million as the latest value for Q4 2025.

  • Quarterly Minority Interest fell 37.74% to $33.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $33.0 million through Dec 2025, down 37.74% year-over-year, with the annual reading at $33.0 million for FY2025, 37.74% down from the prior year.
  • Minority Interest for Q4 2025 was $33.0 million at Bristol Myers Squibb, down from $48.0 million in the prior quarter.
  • The five-year high for Minority Interest was $71.0 million in Q3 2021, with the low at $33.0 million in Q4 2025.
  • Average Minority Interest over 5 years is $58.3 million, with a median of $58.5 million recorded in 2024.
  • The sharpest move saw Minority Interest increased 3.03% in 2021, then crashed 37.74% in 2025.
  • Over 5 years, Minority Interest stood at $60.0 million in 2021, then dropped by 5.0% to $57.0 million in 2022, then decreased by 3.51% to $55.0 million in 2023, then fell by 3.64% to $53.0 million in 2024, then plummeted by 37.74% to $33.0 million in 2025.
  • According to Business Quant data, Minority Interest over the past three periods came in at $33.0 million, $48.0 million, and $54.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.